BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 6726281)

  • 21. [Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].
    Utsugi T; Sone S; Tandon P; Ogawara M; Shimizu E; Nii A; Nakanishi M; Shono M; Ogura T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3161-8. PubMed ID: 3096216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.
    Key ME; Talmadge JE; Fogler WE; Bucana C; Fidler IJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1198-98. PubMed ID: 6957661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC; Rioux J; Tsao MS
    Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction.
    Fogler WE; Fidler IJ
    J Immunol; 1986 Mar; 136(6):2311-7. PubMed ID: 2936824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
    Phillips NC; Tsao MS
    Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE; Fidler IJ
    Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.
    Fidler IJ; Sone S; Fogler WE; Barnes ZL
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1680-4. PubMed ID: 6940181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation.
    Phillips NC; Stewart-Phillips J; Wang P
    J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):185-93. PubMed ID: 8032541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S; Sato K; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo and in vitro NO2 exposures enhance phagocytic and tumoricidal activities of rat alveolar macrophages.
    Sone S; Brennan LM; Creasia DA
    J Toxicol Environ Health; 1983 Jan; 11(1):151-63. PubMed ID: 6827622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage activation by MDP bound to neoglycoproteins: metastasis eradication in mice.
    Roche AC; Bailly P; Monsigny M
    Invasion Metastasis; 1985; 5(4):218-32. PubMed ID: 4008192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of pulmonary macrophage superoxide release and tumoricidal activity following activation by biological response modifiers.
    Drath DB
    Immunopharmacology; 1986 Oct; 12(2):117-26. PubMed ID: 3021650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.
    Fidler IJ
    J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201
    [No Abstract]   [Full Text] [Related]  

  • 36. Age-dependent effects of aminobutyryl muramyl dipeptide on alveolar macrophage function in infant and adult Macaca monkeys.
    Jacobs RF; Wilson CB; Smith AL; Haas JE
    Am Rev Respir Dis; 1983 Nov; 128(5):862-7. PubMed ID: 6638675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
    Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
    Geetha B; Sodhi A
    Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of antitumor properties in alveolar macrophages from protein-calorie malnourished rats.
    Mutsuura S; Sone S; Tsubura E; Tachibana K; Kishino Y
    Cancer Immunol Immunother; 1986; 21(1):63-8. PubMed ID: 3080228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide].
    Maeda M; Ozaki T; Yasuoka S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):135-42. PubMed ID: 2355674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.